{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-083765","form_type":"8-K","ticker":"TCRT","cik":"0001107421","company_name":"Alaunos Therapeutics, Inc.","filed_at":"2024-07-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.192318+00:00","generated_at":"2026-05-31T20:23:32.985229+00:00","sec_items":["5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Alaunos Therapeutics effects 1-for-10 reverse stock split effective July 17, 2024","bullets":["Reverse split effective July 17, 2024 at 5:00 PM ET; every 10 pre-split shares become 1 post-split share.","Stockholders approved reverse split at June 6, 2024 annual meeting; board set 1-for-10 ratio on June 26, 2024.","Ticker TCRT unchanged; new CUSIP 98973P309; trading on split-adjusted basis from July 18, 2024.","Equiniti Trust Company appointed as exchange agent to handle shareholder share exchange."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-083765","json":"https://secwatch.observer/filing/0000950170-24-083765.json","markdown":"https://secwatch.observer/filing/0000950170-24-083765.md","text":"https://secwatch.observer/filing/0000950170-24-083765.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1107421/000095017024083765/0000950170-24-083765-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1107421/000095017024083765/tcrt-20240716.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T20:23:32.985229+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}